www.feizichem.com   Shijiazhuang FeiZi Chemical Technology Co., Ltd.

Driven by the upgrading of downstream manufacturing industries, China’s chemical industry is undergoing a collective transformation, shifting from ordinary adhesive tapes to high‑end functional materials. Not long ago, Crown New Materials, which started out producing adhesive tapes, launched its new share subscription for listing on the Main Board of the Shenzhen Stock Exchange. Its products have entered the industrial chains of leading enterprises including Apple, Huawei, BYD, Tesla and CATL. In 2025, it posted operating revenue of RMB 3.408 billion and attributable net profit of approximately RMB 309 million.

According to statistics from China Adhesives and Tape Industry Association, China’s adhesive output stood at around 9.043 million tons in 2025, with sales volume hitting roughly RMB 121.44 billion. Beset by homogeneous competition in conventional products on one hand, the industry is met with surging new‑material demands from high‑end manufacturing on the other. Competition focus is shifting from cost, scale and distribution channels to formulation R&D, manufacturing precision and customer collaboration, as domestic substitution picks up notable speed.

The same upgrade logic applies to pharmaceutical intermediates and fine chemicals. As pharmaceutical innovation and high‑end manufacturing raise growing requirements for product purity, process stability and customization capacity, opportunities for the localization of high‑end chemicals are emerging.

Shijiazhuang Feizi Chemical Technology Co., Ltd. is a practitioner amid this trend. Founded in 2022, the company specializes in the R&D, production and sales of pharmaceutical intermediates and fine chemical products. Its manufacturing plant, covering 50 mu with over 60 employees, is located in Shijiazhuang Circular Chemical Industry Park, while its R&D center sits in Zhitong Pharma Valley of Shijiazhuang High‑Tech Development Zone, focusing on new‑product development and high‑end custom synthesis.

Its management team mainly comprises core executives from listed pharmaceutical enterprises. Operating under the ISO9001 quality management system, the company maintains ongoing university‑enterprise technical cooperation. At present, its products are supplied to dozens of domestic pharmaceutical manufacturers and research institutes, and exported to Europe, America, Southeast Asia and other overseas markets.

Among its diversified offerings,Aminomethanesulfonic acid (CAS No.: 13881-91-9) ranks as one of its flagship products. As a vital organic sulfonic fine chemical, aminomethanesulfonic acid finds triple applications in pharmaceuticals, agrochemicals and general industry. In pharmaceuticals, it serves in synthetic routes for cefonicid and other cephalosporin medicines, as well as the preparation of 5-mercapto-1,2,3,4-tetrazole-1-methanesulfonic acid and other tetrazole-type pharmaceutical intermediates. In agrochemicals, it is used to synthesize intermediates for glyphosate‑based herbicides. Industrially, thanks to its favorable detergency and metal‑binding properties, it is widely adopted for metal cleaning and degreasing.

The company provides stable supplies of pharmaceutical‑grade aminomethanesulfonic acid with purity above 98%. Rigorous quality control ensures batch‑to‑batch consistency, meeting high‑grade intermediate quality requirements of customers at home and abroad.

Whether for adhesive materials or pharmaceutical intermediates, China’s chemical industry is advancing toward the higher end of the value chain via convergent paths. Shijiazhuang Feizi Chemical Technology Co., Ltd. will keep focusing on high‑end fine chemicals and pharmaceutical intermediates, bolster its R&D and custom‑synthesis strengths, and make solid headway in domestic substitution and industrial upgrading.